XH0L58

ICD-11 MMS 2026-01

Therapy-related myelodysplastic syndrome, NOS

Index terms

  • Therapy-related myelodysplastic syndrome, NOS
  • Therapy-related myelodysplastic syndrome, alkylating agent related
  • Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related

Inclusions

  • Therapy-related myelodysplastic syndrome, alkylating agent related
  • Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related

Sibling codes

  • XH1D20 – Refractory anaemia with excess blasts in transformation
  • XH2N45 – Myelodysplastic syndrome with single lineage dysplasia
  • XH3T02 – Myelodysplastic syndrome with isolated del (5q)
  • XH5B21 – Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
  • XH5DA2 – Myelodysplastic syndrome with multilineage dysplasia
  • XH79X8 – Myelodysplastic syndrome with excess blasts
  • XH7PK9 – Myelodysplastic syndrome, NOS
  • XH8BA8 – Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia

Foundation entity

Therapy-related myelodysplastic syndrome, NOS – http://id.who.int/icd/entity/16422058

Part of: X: Extension Codes